The carbamate moiety has been, and still is, a key functional group in medicinal chemistry programs to develop drugs targeting AChE, for example the drugs pyridostigmine 4 (myasthenia gravis) and rivastigmine 5 (Alzheimer's disease). Here, ACHE is linked to early-onset autosomal dominant Alzheimer disease.